104 results on '"Schlicker, Eberhard"'
Search Results
2. Weak Hypotensive Effect of Chronic Administration of the Dual FAAH/MAGL Inhibitor JZL195 in Spontaneously Hypertensive Rats as Revealed by Area under the Curve Analysis
3. Polypharmacology: promises and new drugs in 2022
4. Effects of the peripheral CB1 receptor antagonist JD5037 in mono— and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension
5. Eighth pharmacologic-historical forum
6. Cross-Talk between the (Endo)Cannabinoid and Renin-Angiotensin Systems: Basic Evidence and Potential Therapeutic Significance
7. Cross-Talk between CB1, AT1, AT2 and Mas Receptors Responsible for Blood Pressure Control in the Paraventricular Nucleus of Hypothalamus in Conscious Spontaneously Hypertensive Rats and Their Normotensive Controls
8. Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?
9. Role of the Histamine H3 Receptor in the Central Nervous System
10. GPR18-Mediated Relaxation of Human Isolated Pulmonary Arteries
11. Beneficial and harmful effects of CB1 and CB2 receptor antagonists on chronotropic and inotropic effects related to atrial β‐adrenoceptor activation in humans and in rats with primary hypertension
12. β1-Blockers Enhance Inotropy of Endogenous Catecholamines in Chronic Heart Failure
13. Autorenverzeichnis
14. Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19
15. Chronic cannabidiol treatment reduces the carbachol-induced coronary constriction and left ventricular cardiomyocyte width of the isolated hypertensive rat heart
16. Reduction of the serotonin 5-HT1B and 5-HT2A receptor-mediated contraction of human pulmonary artery by the combined 5-HT1B receptor antagonist and serotonin transporter inhibitor LY393558
17. Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism
18. Prof. Dr. med. Dr. h. c. mult. Manfred Göthert (1939–2019)
19. Serotonin discovery and stepwise disclosure of 5-HT receptor complexity over four decades. Part II. Some contributions of Manfred Göthert
20. Cannabidiol Affects the Bezold-Jarisch Reflex via TRPV1 and 5-HT3 Receptors and Has Peripheral Sympathomimetic Effects in Spontaneously Hypertensive and Normotensive Rats
21. N-Ethylmaleimide differentiates between the M2- and M4-autoreceptor-mediated inhibition of acetylcholine release in the mouse brain
22. Cannabinoids in arterial, pulmonary and portal hypertension - mechanisms of action and potential therapeutic significance
23. Human presynaptic receptors
24. Engineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled Receptor
25. CB1 receptor activation in the rat paraventricular nucleus induces bi-directional cardiovascular effects via modification of glutamatergic and GABAergic neurotransmission
26. A search for presynaptic inhibitory histamine receptors in guinea-pig tissues: Further H3 receptors but no evidence for H4 receptors
27. Lack of hippocampal CB1 receptor desensitization by Δ9-tetrahydrocannabinol in aged mice and by low doses of JZL 184
28. Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA–salt hypertensive rats
29. The adrenal medulla, not CB1 receptors, mediates the inhibitory effect of acute transverse aortic constriction on the neurogenic vasopressor response
30. A search for functional histamine H4 receptors in the human, guinea pig and mouse brain
31. O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus
32. MH-3: evidence for non-competitive antagonism towards the low-affinity site of β1-adrenoceptors
33. Increased CB2 mRNA and anandamide in human blood after cessation of cannabis abuse
34. Triphasic cardiovascular response to cannabinoids – Focus on underlying mechanisms
35. Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries
36. Do cannabinoids exhibit a tyramine-like effect?
37. The endocannabinoid degradation inhibitors URB597 and JZL184 slightly enhance the inhibitory effect of acute myocardial ischemia on the neurogenic tachycardic and vasopressor responses
38. Involvement of a presynaptic mechanism in the inhibition of the neurogenic vasopressor response by transverse aortic constriction in pithed rats
39. Relaxation of human pulmonary arteries by PPARγ agonists
40. EP3 receptor-mediated contraction of human pulmonary arteries and inhibition of neurogenic tachycardia in pithed rats
41. Acute Myocardial Infarction Inhibits the Neurogenic Tachycardic and Vasopressor Response in Rats via Presynaptic Cannabinoid Type 1 Receptor
42. Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?
43. Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor
44. Noradrenaline release in rodent tissues is inhibited by interleukin-1β but is not affected by urotensin II, MCH, NPW and NPFF
45. Influence of myocardial infarction on the vanilloid TRPV1-and serotonin 5-HT3-receptor-mediated Bezold-Jarisch reflex
46. A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats
47. Prejunctional and peripheral effects of the cannabinoid CB1 receptor inverse agonist rimonabant (SR 141716)
48. Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery
49. Attenuation of allergic contact dermatitis through the endocannabinoid system.
50. Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.